NeoGenomics, Inc. (NASDAQ: NEO) Starts Presentation at 30th Annual ROTH Conference
NeoGenomics (NASDAQ: NEO) provides cancer genetics testing and information services, offering one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. The company is engaged in serving the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks and managed care organizations throughout the United States. NeoGenomics also operates a Pharma Services division that serves pharmaceutical clients in clinical trials and drug development. For more information, visit the company’s website at www.neogenomics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…







